Machine signal
Active cluster sell — 4 distinct insiders, $177K, window ends Sep 1, 2026.
Figures computed from official regulatory filings — .
Analysttarget 3.4 USD (+86%) · consensus 4.2/5 · 3 buy · 2 hold · 0 sell
Ownershipinsiders 4.64% · institutions 62.81% · short 2.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Pulmonx Corp only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
11 buys304 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Radhakrishnan Srikanth | Sell | $13.3K | Unusual size | SEC |
| Lehman David Aaron | Sell | $5K | SEC |
| Lehman David Aaron | Sell | $10.9K | Unusual size | SEC |
| Lehman David Aaron | Sell | $8.6K | SEC |
| Radhakrishnan Srikanth | Sell | $4.8K | SEC |
| French Glendon E. III | Sell | $9.3K | SEC |
| Radhakrishnan Srikanth | Sell | $6K | SEC |
| Radhakrishnan Srikanth | Sell | $8.2K | SEC |
| French Glendon E. III | Sell | $85.4K | SEC |
| Rose Geoffrey Beran | Sell | $3.9K | SEC |
| Rose Geoffrey Beran | Sell | $5K | SEC |
| Rose Geoffrey Beran | Sell | $3.5K | SEC |
| Lehman David Aaron | Sell | $7.9K | SEC |
| Rose Geoffrey Beran | Sell | $5.4K | SEC |
| Sullivan Tiffany | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ferrari Richardtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Melenikiotou Georgia | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Burns Thomas William | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mead Dana G Jr.track record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Florin Daniel P | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| French Glendon E. III | Sell | $21.2K | SEC |
| French Glendon E. III | Sell | $6.4K | SEC |
| Radhakrishnan Srikanth | Sell | $3.3K | SEC |
| Radhakrishnan Srikanth | Sell | $9.2K | Unusual size | SEC |
| Lehman David Aaron | Sell | $7.6K | SEC |